The ROE as of October 2024 (TTM) for Vallon Pharmaceuticals, Inc. (VLON) is -330.86%

According to Vallon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -330.86%. This represents a change of 34.59% compared to the average of -245.82% of the last 4 quarters.

Vallon Pharmaceuticals, Inc. (VLON) Historical ROE (quarterly & annually)

How has VLON ROE performed in the past?

The mean historical ROE of Vallon Pharmaceuticals, Inc. over the last ten years is -1351.04%. The current -330.86% ROE has changed -75.51% with respect to the historical average. Over the past ten years (40 quarters), VLON's ROE was at its highest in in the September 2020 quarter at 4.35%. The ROE was at its lowest in in the March 2023 quarter at -7829.03%.

Vallon Pharmaceuticals, Inc. (VLON) ROE by Quarter and Year

Discovering the peaks and valleys of Vallon Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vallon Pharmaceuticals, Inc. (VLON) Average ROE

How has VLON ROE performed in the past?

The current ROE of Vallon Pharmaceuticals, Inc. (VLON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vallon Pharmaceuticals, Inc. (VLON) ROE vs. Peers

How is VLON’s ROE compared to its peers?

Vallon Pharmaceuticals, Inc.’s ROE is greater than Ikena Oncology, Inc. (-42.81%), less than Foghorn Therapeutics Inc. (140.34%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Clene Inc. (-315.97%), greater than Immunome, Inc. (-157.86%), greater than Zura Bio Limited (-35.45%), greater than Phio Pharmaceuticals Corp. (-142.68%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), less than 180 Life Sciences Corp. (3.04%), greater than Cardio Diagnostics Holdings, Inc. (-308.99%), greater than Palisade Bio, Inc. (-124.86%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Virax Biolabs Group Limited (-115.10%), less than Unicycive Therapeutics, Inc. (294.74%), less than ContraFect Corporation (403.13%), greater than Allarity Therapeutics, Inc. (-704.78%), less than CNS Pharmaceuticals, Inc. (428.91%), greater than Windtree Therapeutics, Inc. (-123.93%), less than Panbela Therapeutics, Inc. (545.45%),

Build a custom stock screener for Vallon Pharmaceuticals, Inc. (VLON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vallon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vallon Pharmaceuticals, Inc. (VLON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vallon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.